Literature DB >> 25324038

Can HTLV-1 infection be a potential risk factor for atherosclerosis?

Parvaneh Layegh1, Ali Shoeibi, Karim Nikkhah, Ali Ghabeli Juibary, Samaheh Raftari, Sahar Darbarpanah, Reza Boroumand, Mahmoudreza Azarpazhooh.   

Abstract

INTRODUCTION: Chronic inflammations including infectious disorders such as HIV infection are now considered as risk factors for atherosclerosis. In this study, conducted for the first time on human subjects, human T-lymphotropic virus type 1 (HTLV-1) infection was examined as a potential risk factor for atherosclerosis.
MATERIALS AND METHODS: This is a matched-pair cross-sectional study on 58 HTLV-1-infected cases and 55 healthy control subjects. The subjects did not have any major cerebrovascular risk factors. Carotid intima-media thickness (IMT) was measured for each patient using the standard protocol of the Atherosclerosis Risk in Communities (ARIC) Study.
RESULTS: The mean age of the subjects was 42.9 ± 10.52 years, and males made up 33% of the population. The difference between the mean IMT of the infected case group and that of the healthy control group was significant (p < 0.05). DISCUSSION: This study indicated that the HTLV-infected individuals showed a greater carotid IMT than the age- and sex-matched control subjects. Observing no other known risk factor for atherosclerosis, we concluded that this significant difference in IMT might support the hypothesis that HTLV-1 infection is an independent risk factor for atherogenesis.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25324038     DOI: 10.1159/000365785

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  6 in total

Review 1.  Viral infection and atherosclerosis.

Authors:  Nima Hemmat; Amin Ebadi; Reza Badalzadeh; Mohammad Yousef Memar; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

2.  Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.

Authors:  Sara Samadi; Samaneh Abolbashari; Zahra Meshkat; Amir Hooshang Mohammadpour; Theodoros Kelesidis; Aida Gholoobi; Mehrane Mehramiz; Mahla Tabadkani; Fatemeh Sadabadi; Razieh Dalirfardouei; Gordon A Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal:  Biofactors       Date:  2019-01-29       Impact factor: 6.113

3.  Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.

Authors:  Tara Sefanya Kairupan; Rie Ibusuki; Motahare Kheradmand; Yasuko Sagara; Eva Mariane Mantjoro; Yora Nindita; Hideshi Niimura; Kazuyo Kuwabara; Shin Ogawa; Noriko Tsumematsu-Nakahata; Yasuhito Nerome; Tetsuhiro Owaki; Toshifumi Matsushita; Shigeho Maenohara; Kazunari Yamaguchi; Toshiro Takezaki
Journal:  J Epidemiol       Date:  2017-05-30       Impact factor: 3.211

4.  Human T-Cell Leukemia Virus Type 1 Infection Is a Risk Factor for Atherosclerosis.

Authors:  Hiroaki Takeoka; Yasuko Sagara; Seizaburo Ksashiwagi; Shigeki Nabeshima
Journal:  J Clin Med Res       Date:  2021-03-19

5.  The effect of HTLV1 infection on inflammatory and oxidative parameters in the liver, kidney, and pancreases of BALB/c mice.

Authors:  Saeed Niazmand; Arezoo Gowhari Shabgah; Sara Hosseinian; Jamshid Gholizadeh Navashenaq; Ali Kamali; Mohammad Reza Khazdair; Yousef Baghcheghi; Mahdiyeh Hedayati-Moghadam
Journal:  Physiol Rep       Date:  2022-04

6.  Cardiovascular risk profile in patients with myelopathy associated with HTLV-1.

Authors:  Fabio Luís Silva do Prado; Renata Prado; Ana Marice Teixeira Ladeia
Journal:  Braz J Infect Dis       Date:  2017-03-07       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.